Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 12 December 2017
Accepted: 15 August 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: This study was approved by Chesapeake Institutional Review Board (CIRB). Consent to participate was declared in written form.
: Not applicable.
: SC, DA, and JJ are employees of Precision Xtract acting as consultants for Novartis Pharmaceutical Corporation; JZ is an employee of Novartis Pharmaceuticals; KB is a consultant for Precision Xtract and Novartis Pharmaceuticals Corporation.